“…Microbial DAAOs possess properties that render them suitable for industrial biotechnological applications: for example, they are stable enzymes and show broad substrate specificity, high turnover number (Table 1 ), and a tight binding with the FAD cofactor. The production of DAAOs in large amounts as recombinant proteins together with the availability of the 3D-structure (e.g., Mattevi et al, 1996 ; Mizutani et al, 1996 ; Umhau et al, 2000 ; Kawazoe et al, 2006 ), allowed the design and production by protein engineering techniques of enzyme variants with new and evolved properties (Pollegioni et al, 2007b ; Rosini et al, 2008 , 2009 , 2010 ; Wang et al, 2008 ; Wong et al, 2010 ; Pollegioni and Molla, 2011 ; Golubev et al, 2014 ).…”